Immunoblotting analysis revealed a dramatic reduction in Cyclin D1 and CDK4 protein expression, and Rb phosphorylation after CMHE treatment (Figure 4C), indicating CMHE-induced inhibition of Cyclin D1/CDK4-Rb cascade in the human BC cells. Here, CDK4 is linked to breast cancer.